Loading...
Market
Will the implantable device show effectiveness in reducing opioid-related deaths in animal studies by March 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Peer-reviewed scientific journals
Story
New Implantable Device to Combat Fentanyl Overdoses in High-Risk Individuals Tested in Animals
Oct 24, 2024, 11:06 AM
Researchers have developed a promising implantable device aimed at counteracting the effects of fentanyl overdoses. Currently tested in animals, the device is designed to be inserted under the skin, similar to a pacemaker, and has the potential to significantly reduce opioid-related deaths, particularly among high-risk individuals. The device works by detecting an opioid overdose and delivering treatment automatically, addressing a critical gap in the current overdose response system, which relies heavily on the immediate availability of naloxone. Naloxone has proven effective in saving lives, but its success is contingent upon someone being present to administer it quickly, a scenario that is not always possible. Continued development of this device could pave the way for its use in humans in the future.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 40% • 25%
40% to 50% • 25%
50% to 60% • 25%
More than 60% • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
US Federal Government • 25%
State Governments • 25%
International Cooperation • 25%
Other • 25%
